KAYTUS Unveils MotusAI Enhancements with OpenClaw for Enterprise-Grade AI Agents
23.4.2026 09:02:00 CEST | Business Wire | Press Release
KAYTUS, a leading provider in AI infrastructure and liquid cooling solutions, today launched new capabilities in its MotusAI AI DevOps platform to accelerate the deployment of enterprise-grade AI agents. By a streamlined three-step integration with the OpenClaw framework, MotusAI provides the compute infrastructure, resource orchestration, and operational support required to address deployment bottlenecks, and enable AI agents to scale from early-stage experimentation to dependable enterprise use.
Key Challenge for Enterprise-Grade AI Agents: Guaranteed Reliability and Performance
As the AI landscape transitions from chatbots to AI agents, enterprises are facing a fundamental constraint: the value of even the most advanced large language model (LLM) depends on the stability and performance of the underlying execution infrastructure. At present, three major bottlenecks are limiting the ability of AI agents to deliver consistent performance and sustainable ROI:
- Wasted Capacity: Traditional one-model-per-GPU deployment approaches often result in significant resource underutilization, particularly when auxiliary models such as embedding and OCR are included, ultimately driving up operational costs.
- Latency and Execution Failures: Multi-step AI agent workflows are highly sensitive to fluctuations in inference performance. Even minor spikes in inference response latency can interrupt execution logic and cause task failures in long-duration or multi-stage workflows.
- Management Complexity: Fragmented model APIs, diverse security requirements, and fluctuating compute demands across different AI agents can significantly increase operational complexity, placing mounting pressure on DevOps and IT teams.
MotusAI: The Intelligent Brain Behind AI Agents
MotusAI delivers a high-availability architecture that decouples agent logic from model inference, providing four clear and tangible benefits for enterprise users:
- Maximize Infrastructure ROI: By unlocking resource sharing across model workloads, MotusAI enables dynamic GPU utilization at scale. Enterprises can deploy and support far more AI agent instances on the same infrastructure, boosting compute efficiency, increasing return on investment, and reducing total cost of ownership (TCO).
- Guaranteed Task Continuity: MotusAI enables stable, continuous AI agent operations through SLA-grade monitoring of critical inference metrics such as TTFT (Time to First Token) and TPOT (Time Per Output Token). Combined with automatic elastic scaling, this capability helps AI agents reduce latency, prevent task disruptions, and deliver a smoother, more dependable user experience during traffic surges and peak demands.
- Accelerated Time-to-Market: MotusAI’s centralized Model Hub includes pre-integrated support for more than 50 mainstream open-source models, such as Llama 3, Mistral, and DeepSeek. Combined with a unified API gateway, it allows developers to rapidly select and deploy best-fit model capabilities for AI agents, reducing integration time from days to minutes.
- Precision Cost Management: With task-level cost tracking, MotusAI gives enterprises precise visibility into the compute cost of every AI agent mission, helping them clearly evaluate the investment required for individual AI workflows.
MotusAI and OpenClaw Integration: A Three-Step Framework
To bring these benefits into production, MotusAI delivers deep integration with OpenClaw, an emerging open-source framework for AI agents. Through a streamlined three-step operation, enterprises can progress from initial integration to fully operational AI agent deployment:
- Optimized Decoupling: OpenClaw manages task orchestration and execution logic on standard x86 servers, while MotusAI handles compute-intensive model inference to AI servers. This “brain-body” separation enables independent optimization of orchestration and inference workloads, ensuring that each subsystem operates on the substructure best aligned with its functional requirements.
- Seamless No-Code Integration: With one-click LLM deployment through MotusAI, users can connect OpenClaw to the MotusAI unified API and instantly equip AI agents with enterprise-grade compute power, without any code modifications.
- Automated Performance Optimization: MotusAI provides real-time load balancing and dynamic resource reclamation, enabling OpenClaw agents to remain focused on execution logic, while the platform itself continuously optimizes backend resource allocation based on live workload conditions.
Conclusion
As AI agents emerge as a core engine of digital productivity, the need for a stable and efficient compute foundation becomes indispensable. With the advanced orchestration capabilities of MotusAI and its integration with the OpenClaw framework, KAYTUS is providing the essential infrastructure required to translate AI agent potential into dependable, scalable, and enterprise-ready business value.
About KAYTUS
KAYTUS is a leading provider of AI infrastructure and liquid cooling solutions, delivering a diverse range of innovative, open, and eco-friendly products for cloud, AI, edge computing, and other emerging applications. With a customer-centric approach, KAYTUS is agile and responsive to user needs through its adaptable business model. Discover more at KAYTUS.com and follow us on LinkedIn and X
View source version on businesswire.com: https://www.businesswire.com/news/home/20260423471448/en/
Contacts
Media Contacts
media@kaytus.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Chiesi Reports Strong FY2025 Financial and Sustainability Results and Announces Leadership Transition Highlights23.4.2026 12:10:00 CEST | Press Release
Chiesi Group (“Chiesi”), an international research‑focused biopharmaceutical company and certified B Corp, today announced its financial results for the year ended 31 December 2025. Chiesi reported €3.625 billion in consolidated revenues, an increase of 8.2% at constant exchange rates (CER) compared to 2024. EBITDA reached €931 million (25.7%). Chiesi closed 2025 with a positive Net Financial Position (cash minus financial liabilities including leasing) of €729 million, improving by €194 million versus 2024, reconfirming the Group’s capacity to self‑finance its investment strategy. The Group’s three therapeutic areas – Respiratory (Air), Rare Diseases (Rare), and Specialty Care (Care) – all contributed well to the year’s sales. A strong performance in the Global Rare Disease business unit saw sales increase to €906 million, +22.3% at CER, representing 50% of total Group growth across the U.S., Europe and international markets. The Air franchise sales reached €1.886 billion, up 3.9% at
REPLY S.p.A.: Shareholders’ Meeting Approves the 2025 Financial Statements23.4.2026 12:05:00 CEST | Press Release
The General Shareholders’ meeting of Reply S.p.A. [EXM, STAR: REY] held today approved the Financial Statements for the financial year 2025, confirming the distribution of a gross dividend of €1.35 per share. The dividend will be paid on 20 May 2026, with dividend date set on 18 May 2026 (record date on 19 May 2026). Approval of the 2025 financial statements The Reply Group closed the 2025 financial year with a consolidated turnover of €2,483.6 million, recording a 8.0% increase compared to €2,300.5 million in 2024. Consolidated EBITDA was €467.6 million, up 13.9% compared to €410.6 million recorded for the year 2024. EBIT, from January to December, was €397.1 million, up 18.5% compared to €330.4 million recorded for the year 2024. The Group net profit was at €250.9 million. In 2024, the corresponding figure was €211.1 million. The Shareholders’ Meeting also approved the following resolutions, in accordance with the proposals formulated by the Board of Directors: Authorization to purch
Demand for GP Financing Is Rising, but the Managers Who Need It Most Are Finding It Hardest to Access23.4.2026 10:00:00 CEST | Press Release
Corpay Private Markets, formerly Alpha Private Markets, today publishes the fourth edition of its Lender Book Report, focusing on GP financing across private markets. While demand for GP-level liquidity is rising – driven by longer fundraising cycles, slower exit activity, and increasing GP commitment requirements – access to financing is not expanding evenly. That is the central finding of the latest Lender Book Report. Unlike most research in the fund finance sector, which draws on surveys and reflects market sentiment, the Lender Book Report series is built on proprietary data. This edition combines insights from Alpha Match, Corpay Private Markets' lending intelligence platform tracking 500+ active lenders, with anonymised data from recent GP financing transactions. The data reveals a structural gap. Although the number of GP facility lenders tracked has more than doubled since 2024, lender appetite remains concentrated around established managers with scale and predictable managem
Pantheon Expands Global Private Wealth Platform with Infrastructure Secondaries Fund Launch23.4.2026 10:00:00 CEST | Press Release
Pantheon, a leading global private markets investor, today announced the regulatory approval for the Pantheon Global Infrastructure Secondaries Fund (“PGIS”). Domiciled in Luxembourg, the evergreen fund represents a significant milestone in Pantheon’s private wealth strategy and the expansion of the firm’s evergreen offering. The launch of PGIS now cements Pantheon’s global evergreen offerings across private equity, private credit secondaries, and infrastructure secondaries and complements its existing international evergreen suite alongside Pantheon Global Private Equity (PGPE), and Pantheon Global Credit Secondaries Fund (PGCS). PGIS aims to comprise a high-conviction portfolio and is designed to provide professional investors with access to a diversified portfolio of global infrastructure secondaries assets, managed by the firm’s distinguished institutional infrastructure arm. Jérôme Duthu-Bengtzon, Partner and Portfolio Manager of PGIS, said, “The new fund will aim to combine the b
Samsung Epis Holdings Reports First Quarter 2026 Financial Results23.4.2026 08:54:00 CEST | Press Release
Samsung Epis Holdings (KRX: 0126Z0), an investment company dedicated to innovations in biopharmaceuticals and biotechnology, today announced its financial results for the first quarter of fiscal year 2026. “Samsung Bioepis delivered solid growth this quarter driven by continued momentum across our biosimilar portfolio," said Kyung-Ah Kim, President and Chief Executive Officer (CEO) of Samsung Epis Holdings. “We are further strengthening our position through new global partnerships and continued portfolio expansion. As we mark the 10th anniversary of the launch of our first biosimilar in Europe, we remain focused on building on our legacy while investing strategically to support long-term growth. We remain committed to delivering sustainable value for our shareholders.” First Quarter 2026 Results On a standalone basis, in the first quarter of 2026, Samsung Bioepis posted a revenue of KRW 454.9 billion with an operating profit of KRW 144.0 billion. Revenue and operating profit in the fou
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom